Latest filing published 19 Dec 2017 for Coherus Oncology, Inc..
Filing timeline
BuySaleInsider track record
Alan C. Herman: trading record in brief
Alan C. Herman is a declared insider of Coherus Oncology, Inc., with filings sourced from SEC (Form 4). We count 49 filings; the first trade dates from 12 November 2014 and the latest from 15 December 2017.
On the market, this insider has only sold: 37 sales, €5.3M in total. The rest of the record consists of 2 share grants and 6 option exercises. So far in 2017, the count stands at no purchases and 10 sales.
The latest filing, published on 19 December 2017, reports a share grant in Coherus Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alan C. Herman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 809 shares0Common Stock, $0.0001 par valueSEC:0000899243-17-029155:0
- 17,535 shares@ US$15.0235.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-020046:0
- 600 shares@ US$15.001.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018067:0
- 9,601 shares@ US$20.20Common Stock, $0.0001 par valueSEC:0000899243-17-015285:0
- 1,732 shares@ US$20.98Common Stock, $0.0001 par valueSEC:0000899243-17-015285:1
- 11,333 shares@ US$20.00Common Stock, $0.0001 par valueSEC:0000899243-17-011610:0
- 11,333 shares@ US$20.73Common Stock, $0.0001 par valueSEC:0000899243-17-009488:0
- 11,333 shares@ US$24.19Common Stock, $0.0001 par valueSEC:0000899243-17-006341:0
- 11,333 shares@ US$27.37Common Stock, $0.0001 par valueSEC:0000899243-17-002713:0
- 10,650 shares@ US$27.90Common Stock, $0.0001 par valueSEC:0000899243-17-000442:0
- 683 shares@ US$28.60Common Stock, $0.0001 par valueSEC:0000899243-17-000442:1
- 3,200 shares@ US$27.01Common Stock, $0.0001 par valueSEC:0001140361-16-088854:0
- 8,133 shares@ US$27.55Common Stock, $0.0001 par valueSEC:0001140361-16-088854:1
- 11,333 shares@ US$27.53Common Stock, $0.0001 par valueSEC:0000899243-16-032715:0
- 8,096 shares@ US$25.47Common Stock, $0.0001 par valueSEC:0000899243-16-031223:0
- 3,237 shares@ US$26.26Common Stock, $0.0001 par valueSEC:0000899243-16-031223:1
- 16,999 shares@ US$29.99Common Stock, $0.0001 par valueSEC:0000899243-16-028532:0
- 11,333 shares@ US$25.54Common Stock, $0.0001 par valueSEC:0000899243-16-026203:0
- 4,250 shares@ US$16.8910.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-024357:0
- 4,250 shares@ US$18.6711.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-021654:0
- 3,698 shares@ US$19.139.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-019188:0
- 552 shares@ US$19.631.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-019188:1
- 3,273 shares@ US$21.20Common Stock, $0.0001 par valueSEC:0000899243-16-017722:0
- 977 shares@ US$21.89Common Stock, $0.0001 par valueSEC:0000899243-16-017722:1
- 485 shares@ US$15.001.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-16-015165:0
25 of 49 declarations
